GAPLINC and colorectal carcinoma: Several studies have shown that aberrant expression or mutations of various lncRNAs, including MALAT1, GAPLINC, NEAT1, and CCAT2, enhance the metastasis, invasion, and proliferation of CRC cells.10, 11, 12, 13